- Home
- RCUS vs MQY Comparison
RCUS vs MQY Comparison
Compare RCUS & MQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- MQY
- Stock Information
- Founded
- RCUS 2015
- MQY 1994
- Country
- RCUS United States
- MQY United States
- Employees
- RCUS N/A
- MQY N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- MQY Investment Bankers/Brokers/Service
- Sector
- RCUS Health Care
- MQY Finance
- Exchange
- RCUS Nasdaq
- MQY Nasdaq
- Market Cap
- RCUS 906.4M
- MQY 776.5M
- IPO Year
- RCUS 2018
- MQY N/A
- Fundamental
- Price
- RCUS $9.32
- MQY $10.85
- Analyst Decision
- RCUS Buy
- MQY
- Analyst Count
- RCUS 8
- MQY 0
- Target Price
- RCUS $20.86
- MQY N/A
- AVG Volume (30 Days)
- RCUS 721.6K
- MQY 184.8K
- Earning Date
- RCUS 08-07-2025
- MQY 01-01-0001
- Dividend Yield
- RCUS N/A
- MQY 4.73%
- EPS Growth
- RCUS N/A
- MQY N/A
- EPS
- RCUS N/A
- MQY N/A
- Revenue
- RCUS $141,000,000.00
- MQY N/A
- Revenue This Year
- RCUS N/A
- MQY N/A
- Revenue Next Year
- RCUS $28.73
- MQY N/A
- P/E Ratio
- RCUS N/A
- MQY N/A
- Revenue Growth
- RCUS N/A
- MQY N/A
- 52 Week Low
- RCUS $6.50
- MQY $9.82
- 52 Week High
- RCUS $18.98
- MQY $12.52
- Technical
- Relative Strength Index (RSI)
- RCUS 55.03
- MQY 41.61
- Support Level
- RCUS $9.14
- MQY $10.78
- Resistance Level
- RCUS $10.34
- MQY $11.12
- Average True Range (ATR)
- RCUS 0.48
- MQY 0.08
- MACD
- RCUS 0.07
- MQY -0.01
- Stochastic Oscillator
- RCUS 48.91
- MQY 21.79
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About MQY Blackrock MuniYield Quality Fund Inc.
Blackrock Muniyield Quality Fund Inc is a closed-end management investment company. The company's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.